Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics

American Journal of Clinical Pathology

Volumn 127, Issue 4, 2007, Pages 511-517

  Warnke, Roger A ^a   Jones, Dan ^b   Hsi, Eric D ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angioimmunoblastic; Atypical hyperplasia; B cell proliferations; Epstein Barr virus; Genotype; Hodgkin; Nodal; Peripheral; Phenotype; T cell lymphoma

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD4 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CXC CHEMOKINE LIGAND 13; CXCL1 CHEMOKINE; CYCLIN D1; CYCLOSPORIN; HYDROXYCHLOROQUINE; PHENYTOIN; PREDNISONE; PROTEIN BCL 6; THALIDOMIDE; UNCLASSIFIED DRUG;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; B LYMPHOCYTE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC TEST; EPSTEIN BARR VIRUS; GENE MUTATION; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; KIKUCHI DISEASE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MASTOCYTOSIS; MEMORY T LYMPHOCYTE; OVARY FOLLICLE CELL; PERIPHERAL T CELL LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, T-CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 34247108699     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QBLAMA321K9AD2XK     Document Type: Conference Paper

References (66)

1. Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy: diagnosis and clinical course. Am J Med. 1975;59:803-818.
2. Balague O, Martinez A, Colomo L, et al. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathological features. Am J Surg Pathol. In press.
3. Patsouris E, Noel H, Lennert K. Angioimmunoblastic lymphadenopathy: type of T-cell lymphoma with a high content of epithelioid cells: histopathology and comparison with lymphoepithelioid cell lymphoma. Am J Surg Pathol. 1989;13:262-275.
4. Tan B, Warnke R, Arber D. The frequency of B- and T-cell clones and EBV in T-cell lymphomas: a comparison between AILT and PTCL-NOS. J Mol Diagn. 2006;8:466-475.
5. Namikawa R, Suchi T, Ueda R, et al. Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique. Am J Pathol. 1987;127:279-287.
6. Schlegelberger B, Zwingers T, Hohenadel K, et al. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol. 1996;14:593-599.
7. Geissinger E, Bonzheim I, Krenacs L, et al. Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies. J Mol Diagn. 2005;7:455-464.
8. Leung CY, Ho FC, Srivastava G, et al. Usefulness of follicular dendritic cell pattern in classification of peripheral T-cell lymphomas. Histopathology. 1993;23:433-437.
9. Jones D, Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol. 1998;22:956-964.
10. Troxell ML, Schwartz EJ, van de Rijn M, et al. Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. Appl Immunohistochem Mol Morphol. 2005;13:297-303.
11. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T-cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633.
12. Attygalle AD, Diss TC, Munson P, et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2004;28:54-61.
13. Ree HJ, Kadin ME, Kikuchi M, et al. bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol. 1999;30:403-411.
14. Grogg KL, Attygalle AD, Macon WR, et al. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood. 2005;106:1501-1502.
15. Reichard KK, Schwartz EJ, Higgins JP, et al. CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells. Mod Pathol. 2006;19:337-343.
16. Dogan A, Ngu LS, Ng SH, et al. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia. 2005;19:873-875.
17. Ree HJ, Kadin ME, Kikuchi M, et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol. 1998;22:643-655.
18. Ottaviani G, Bueso-Ramos CE, Seilstad K, et al. The role of the perifollicular sinus in determining the complex immunoarchitecture of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2004;28:1632-1640.
19. Geissinger E, Odenwald T, Lee SS, et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch. 2004;445:334-343.
20. de Leval L, Savilo E, Longtine J, et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol. 2001;25:395-400.
21. Jiang L, Jones D, Medeiros LJ, et al. Peripheral T-cell lymphoma with a "follicular" pattern and the perifollicular sinus phenotype. Am J Clin Pathol. 2005;123:448-455.
22. Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol. 2005;29:1284-1293.
23. Quintanilla-Martinez L, Preffer F, Rubin D, et al. CD20+ T-cell lymphoma: neoplastic transformation of a normal T-cell subset. Am J Clin Pathol. 1994;102:483-489.
24. Blakolmer K, Vesely M, Kummer JA, et al. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas. Mod Pathol. 2000;13:766-772.
25. Arber D, Weiss L. CD15: a review. Appl Immunohistochem. 1993;1:17-30.
26. Yatabe Y, Suzuki R, Matsuno Y, et al. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases. Pathol Int. 2001;51:747-761.
27. Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol. 2000;114:236-247.
28. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117:368-379.
29. Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T-cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection: a different subtype of AILD-TL? Leukemia. 2002;16:2134-2141.
30. Ohshima K, Takeo H, Kikuchi M, et al. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology. 1994;25:569-579.
31. Weiss LM, Jaffe ES, Liu XF, et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992;79:1789-1795.
32. Advani R, Warnke R, Sikic BI, et al. Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol. 1997;8:601-603.
33. Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol. 1999;23:1233-1240.
34. Barry TS, Jaffe ES, Sorbara L, et al. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol. 2003;27:1513-1522.
35. Poppema S, Maggio E, van den Berg A. Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma. 2004;45:423-431.
36. Rao VK, Straus SE. Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology. 2006;11:15-23.
37. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98:194-200.
38. Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541-1550.
39. Christopoulos C, Papadaki T, Vlavianos P, et al. Hodgkin's disease in a patient with common variable immunodeficiency. J Clin Pathol. 1995;48:871-873.
40. Elenitoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol. 1997;14:35-47.
41. Gottesman SR, Haas D, Ladanyi M, et al. Peripheral T-cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review. Leuk Lymphoma. 1999;32:589-595.
42. Sander CA, Medeiros LJ, Weiss LM, et al. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170-1182.
43. Cunningham-Rundles C, Cooper DL, Duffy TP, et al. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002;69:171-178.
44. Desar IM, Keuters M, Raemaekers JM, et al. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency: a report of two cases and a brief review of the literature. Neth J Med. 2006;64:136-140.
45. Kinlen LJ, Webster AD, Bird AG, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1:263-266.
46. Mellemkjaer L, Hammarstrom L, Andersen V, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130:495-500.
47. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med. 1988;318:733-741.
48. Kanegane H, Bhatia K, Gutierrez M, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 1998;91:2085-2091.
49. Kanegane H, Miyawaki T, Yachie A, et al. Development of EBV-positive T-cell lymphoma following infection of peripheral blood T-cells with EBV. Leuk Lymphoma. 1999;34:603-607.
50. Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000;96:443-451.
51. Gaillard F, Mechinaud-Lacroix F, Papin S, et al. Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol. 1992;98:324-333.
52. Mori M, Kurozumi H, Akagi K, et al. Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis [letter]. N Engl J Med. 1992;327:58.
53. Katano H, Ali MA, Patera AC, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2004;103:1244-1252.
54. Choi TS, Doh KS, Kim SH, et al. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. 2003;148:730-736.
55. Rijlaarsdam U, Scheffer E, Meijer CJ, et al. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol. 1991;24:216-220.
56. Abbondanzo SL, Irey NS, Frizzera G. Dilantin-associated lymphadenopathy: spectrum of histopathologic patterns. Am J Surg Pathol. 1995;19:675-686.
57. Braddock SW, Harrington D, Vose J. Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy: use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin. J Am Acad Dermatol. 1992;27:337-340.
58. Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis): a clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol. 1995;19:798-809.
59. Tsang WY, Chan JK, Ng CS. Kikuchi's lymphadenitis: a morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol. 1994;18:219-231.
60. Onciu M, Medeiros LJ. Kikuchi-Fujimoto lymphadenitis. Adv Anat Pathol. 2003;10:204-211.
61. Pileri SA, Facchetti F, Ascani S, et al. Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy. Am J Pathol. 2001;159:915-924.
62. Macari M, Hines J, Balthazar E, et al. Mesenteric adenitis: CT diagnosis of primary versus secondary causes, incidence, and clinical significance in pediatric and adult patients. AJR Am J Roentgenol. 2002;178:853-858.
63. Lee JH, Rhee PL, Lee JK, et al. The etiology and clinical characteristics of mesenteric adenitis in Korean adults. J Korean Med Sci. 1997;12:105-110.
64. Valent P, Horny HP, Li CY, et al, eds. Mastocytosis. In: Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:293-302. World Health Organization Classification of Tumours.
65. Robyn J, Metcalfe DD: Systemic mastocytosis. Adv Immunol. 2006;89:169-243.
66. Escribano L, Diaz-Agustin B, Nunez R, et al. Abnormal expression of CD antigens in mastocytosis. Int Arch Allergy Immunol. 2002;127:127-132.